SANA - Sana Biotechnology, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.5 1.4 (31.02%) -0.03 (-0.57%) -0.02 (-0.41%) -0.02 (-0.41%) -0.01 (-0.22%) 1.41 (31.15%) -0.01 (-0.24%) -0.01 (-0.24%)

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.39
Diluted EPS:
-0.39
Basic P/E:
-15.1179
Diluted P/E:
-15.1179
RSI(14) 1m:
38.58
VWAP:
5.91
RVol:

Events

Period Kind Movement Occurred At
1m Price increase 1m 5.93 +0.08 (+1.34%) Oct 15 16:19
1m Price increase 1m 5.93 +0.08 (+1.34%) Oct 15 16:19
1m Price increase 1m 5.93 +0.08 (+1.34%) Oct 15 16:19
1m Price increase 1m 5.93 +0.08 (+1.34%) Oct 15 16:19
1m Price increase 1m 5.93 +0.08 (+1.34%) Oct 15 16:19

Related News